FMDE 📈 Fidelity Covington Trust - Overview

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • • Mid-Cap Blend

FMDE: Stocks, Mid-Cap, Equities, US, Domestic, Foreign

The Fidelity Covington Trust, listed on the NYSE ARCA under the ticker FMDE, is an exchange-traded fund (ETF) that primarily focuses on investing in common stocks within the mid-cap segment of the U.S. equity market. Specifically, it aims to allocate at least 80% of its assets in stocks that are components of the Russell Midcap Index. This index is market capitalization-weighted, meaning that the stocks with the largest market capitalization have a greater influence on the index's performance. The Russell Midcap Index is designed to track the performance of the mid-cap segment of the U.S. equity market, which typically includes companies with market capitalizations between $2 billion and $10 billion.

The investment approach of the Fidelity Covington Trust is research-driven, where the adviser seeks to identify long-term drivers of stock returns. This involves analyzing various factors that can influence stock performance, including valuation, growth, quality, and other relevant metrics. By considering these factors, the adviser aims to construct a portfolio that can potentially outperform the broader mid-cap market over the long term. The fund's category is classified as Mid-Cap Blend, indicating that it seeks to balance value and growth investing within the mid-cap space, rather than focusing solely on one style. This blend approach can help in managing risk and potentially enhancing returns by diversifying across different investment styles.

As an ETF, the Fidelity Covington Trust offers investors the benefits of diversification, liquidity, and transparency. By tracking the Russell Midcap Index, the fund provides exposure to a broad range of mid-cap stocks, which can be an attractive option for investors looking to tap into the growth potential of mid-sized companies. The ETF structure also allows for flexibility in trading, as shares can be bought and sold throughout the trading day, similar to individual stocks. This can be particularly useful for investors who want to quickly adjust their portfolios in response to changing market conditions or investment strategies.

Additional Sources for FMDE ETF

FMDE ETF Overview

Market Cap in USD 2,337m
Category Mid-Cap Blend
TER 0.23%
IPO / Inception 2007-12-20

FMDE ETF Ratings

Growth 5y 75.6%
Fundamental -
Dividend 44.0%
Rel. Strength Industry 3.25
Analysts -
Fair Price Momentum 33.77 USD
Fair Price DCF -

FMDE Dividends

Dividend Yield 12m 1.08%
Yield on Cost 5y 1.48%
Annual Growth 5y 275.19%
Payout Consistency 66.7%

FMDE Growth Ratios

Growth Correlation 3m 23.1%
Growth Correlation 12m 90%
Growth Correlation 5y 93.4%
CAGR 5y 31.47%
CAGR/Mean DD 5y 16.57
Sharpe Ratio 12m 1.52
Alpha 1.53
Beta 1.00
Volatility 14.61%
Current Volume 122k
Average Volume 20d 658.9k
What is the price of FMDE stocks?
As of January 17, 2025, the stock is trading at USD 33.98 with a total of 122,026 shares traded.
Over the past week, the price has changed by +4.04%, over one month by -0.69%, over three months by +3.61% and over the past year by +27.02%.
Is Fidelity Covington Trust a good stock to buy?
Yes. Based on ValueRay Analyses, Fidelity Covington Trust (NYSE ARCA:FMDE) is currently (January 2025) a good stock to buy. It has a ValueRay Growth Rating of 75.62 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of FMDE as of January 2025 is 33.77. This means that FMDE is currently overvalued and has a potential downside of -0.62%.
Is FMDE a buy, sell or hold?
Fidelity Covington Trust has no consensus analysts rating.
What are the forecast for FMDE stock price target?
According to ValueRays Forecast Model, FMDE Fidelity Covington Trust will be worth about 37.6 in January 2026. The stock is currently trading at 33.98. This means that the stock has a potential upside of +10.51%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 37.6 10.5%